Gene Expression and Mutational Profile in BAP-1 Inactivated Melanocytic Lesions of Progressive Malignancy from a Patient with Multiple Lesions
Related Experiment Video
Updated: Oct 6, 2025

Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Yan Zhou1, Andrew C Nelson1,2, Yuyu He1,2
1Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.
Abstract:
BAP-1 (BRCA1-associated protein 1) inactivated melanocytic lesions are a group of familial or sporadic lesions with unique histology and molecular features. They are of great clinical interest, at least in part due to the potential for malignant transformation and association with a familial cancer predisposition syndrome. Here, we describe a patient with multiple spatially and temporally distinct melanocytic lesions with loss of BAP1 expression by immunohistochemistry. RNA sequencing was performed on three independent lesions spanning the morphologic spectrum: a benign nevus, an atypical tumor, and a melanoma arising from a pre-existing BAP1-inactivated nevus. The three lesions demonstrated largely distinct gene expression and mutational profiles. Gene expression analysis revealed that genes involved in receptor protein kinase pathways were progressively upregulated from nevus to melanoma. Moreover, a clear enrichment of genes regulated in response to UV radiation was found in the melanoma from this patient, as well as upregulation of MAPK pathway-related genes and several transcription factors related to melanomagenesis.
Insights
BRCA1-associated protein 1 (BAP1) inactivated melanocytic lesions show distinct molecular profiles. This study reveals progressive gene expression changes from nevus to melanoma, highlighting UV radiation and MAPK pathway involvement.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- BAP1-inactivated melanocytic lesions are clinically significant due to malignant transformation potential and association with cancer predisposition.
- Understanding the molecular progression of these lesions is crucial for risk assessment and management.
Observation:
- A patient presented with multiple melanocytic lesions exhibiting loss of BAP1 expression.
- RNA sequencing analyzed three distinct lesions: a benign nevus, an atypical tumor, and a melanoma.
- These lesions displayed unique gene expression and mutational profiles.
Findings:
- Progressive upregulation of receptor protein kinase pathways from nevus to melanoma.
- Enrichment of UV-regulated genes and upregulation of MAPK pathway genes in the melanoma.
- Identification of key transcription factors implicated in melanomagenesis.
Implications:
- This research provides insights into the molecular drivers of BAP1-inactivated melanoma progression.
- Findings may inform diagnostic and therapeutic strategies for BAP1-related cancers.
- Highlights the role of UV radiation and specific signaling pathways in melanoma development.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Intrinsic Apoptotic Pathway

